Gout

DECT-Detected Cardiovascular Monosodium Urate Deposits More Common in Patients With Gout

Researchers assessed coronary calcium score and cardiovascular monosodium urate deposits detected by dual-energy computed tomography in patients with gout vs healthy controls.

Pharmacist-Managed Titration May Effectively Lower Serum Urate Levels in Gout

Researchers aimed to create a pharmacist-managed referral for the titration of urate-lowering therapy to target serum uric acid levels in patients with gout.

Gout Risk During Tuberculosis Treatment Higher With Obesity, Chronic Kidney Disease, Hyperuricemia

Researchers investigated the clinical features and risk factors for gout during tuberculosis treatment in a South Korean population.

Heart Disease May Increase Risk for Allopurinol-Linked Cutaneous Adverse Events

Heart disease is associated with an increased risk for hospital admission for allopurinol-associated severe cutaneous adverse reactions.

Chronic Kidney Disease Progression, Recovery Common in Patients With Gout Using Urate-Lowering Drugs

Researchers investigated the association between exposure to urate-lowering drugs and the progression and recovery of chronic kidney disease in patients with gout.

Canagliflozin May Reduce Gout-Related Adverse Events, Uric Acid Levels in T2D

Researchers investigated the effects of canagliflozin on serum urate levels and gout in patients with type 2 diabetes.

Modifiable Risk Factors Tied to Prevention of Hyperuricemia, Gout

Four modifiable risk factors — body mass index (BMI), the Dietary Approaches to Stop Hypertension (DASH) diet, alcohol use, and diuretic use — could individually account for a notable proportion of hyperuricemia and possibly gout cases.

Systematic Review of Guidelines, Consensus Statements for Hyperuricemia and Gout Treatment

Investigators evaluated the quality and consistency of guidance documents for the treatment of gout and hyperuricemia.

Gout May Increase Risk for Progression of Chronic Kidney Disease

Gout is associated with an elevated risk for chronic kidney disease (CKD) progression.

Gout Flare Variation Hinders Reporting in Clinical Trials

The study describes the variations of gout flares and assesses the different methods of gout flare reporting in clinical trials.